Atlas of Genetics and Cytogenetics in Oncology and Haematology


Home   Genes   Leukemias   Solid Tumors   Cancer-Prone   Deep Insight   Case Reports   Journals  Portal   Teaching   
X Y 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 NA

Database Archives 2018 Volume 22

SectionTitleAuthorsAddress
GenesAFDN (afadin, adherens junction formation factor)Huret JL, Dessen Phttp://atlasgeneticsoncology.org/Genes/AF6ID6.html
GenesFZD5 (frizzled class receptor 5)Esposito Ihttp://atlasgeneticsoncology.org/Genes/FZD5ID47614ch2q33.html
GenesFZD6 (Frizzled class receptor 6)Beghini A, Postorino Ghttp://atlasgeneticsoncology.org/Genes/FZD6ID40656ch8q22.html
GenesHNRNPA1 (Heterogeneous Nuclear Ribonucleoprotein A1)http://atlasgeneticsoncology.org/Genes/HNRNPA1ID43803ch12q13.html
GenesLIPE (lipase E, hormone sensitive type)Gök Shttp://atlasgeneticsoncology.org/Genes/LIPEID43466ch19q13.html
GenesMAD1L1 (mitotic arrest deficient 1 like 1)Lima K, Machado-Neto JAhttp://atlasgeneticsoncology.org/Genes/MAD1L1ID41226ch7p22.html
GenesNCOA1 (Nuclear receptor coactivator 1)Kazan HH, Gunduz U.http://atlasgeneticsoncology.org/Genes/NCOA1ID44097ch2p23.html
GenesNOL4L (nucleolar protein 4 like)Huret JLhttp://atlasgeneticsoncology.org/Genes/NOL4LID51676ch20q11.html
GenesNRIP1 (nuclear receptor interacting protein 1)Cavaillès V, Lapierre Mhttp://atlasgeneticsoncology.org/Genes/NRIP1ID44067ch21q11.html
GenesPALB2 (partner and localizer of BRCA2)Hanenberg H, Andreassen PRhttp://atlasgeneticsoncology.org/Genes/PALB2ID46402ch16p12.html
GenesPIK3CA (phosphoinositide-3-kinase, catalytic, alpha polypeptide)Phillips J, Domingo Ehttp://atlasgeneticsoncology.org/Genes/PIK3CAID415ch3q26.html
GenesPNP (Purine Nucleoside Phosphorylase)Gurbanov R, Tunçer Shttp://atlasgeneticsoncology.org/Genes/PNPID46893ch14q11.html
GenesPOLD1 (DNA polymerase delta 1, catalytic subunit) Domingo Ehttp://atlasgeneticsoncology.org/Genes/POLD1ID41770ch19q13.html
GenesPOLE (DNA polymerase epsilon, catalytic subunit)Domingo Ehttp://atlasgeneticsoncology.org/Genes/POLEID41773ch12q24.html
GenesPRKAA1 (protein kinase AMP-activated catalytic subunit alpha 1)Seza, E.G., Güderer, I., Ermis, C. Banerjee, S.http://atlasgeneticsoncology.org/Genes/PRKAA1ID43428ch5p13.html
GenesPRXL2C (Peroxiredoxin like 2C)Huret JLhttp://atlasgeneticsoncology.org/Genes/PRXL2CID60014ch9q22.html
GenesXRCC2 (X-ray repair cross complementing 2)Andreassen PR, Hanenberg Hhttp://atlasgeneticsoncology.org/Genes/XRCC2ID334ch7q36.html
Leukemias-20 or monosomy 20Zamecnikova Ahttp://atlasgeneticsoncology.org/Anomalies/mono20ID1079.html
LeukemiasAcute Lymphoblastic Leukemia with HypereosinophiliaMohamed ANhttp://atlasgeneticsoncology.org/Anomalies/ALLHypereoID1184.html
LeukemiasBurkitt's lymphoma (BL)Juárez Salcedo LM, Corazón Monzón A, Dalia Shttp://atlasgeneticsoncology.org/Anomalies/BurkittID2077.html
LeukemiasChronic Eosinophilic Leukemia-Not Otherwise Specified (CEL-NOS)Mohamed ANhttp://atlasgeneticsoncology.org/Anomalies/ChrEosinoLeukID1340.html
LeukemiasEBV positive DLBCL, NOSChen DBhttp://atlasgeneticsoncology.org/Anomalies/EBV_DLBCLID1834.html
LeukemiasExtranodal NK/T-cell lymphoma, nasal type (ENKL)Juárez Salcedo LM, Conde Royo D, Dalia S.http://atlasgeneticsoncology.org/Anomalies/ExtranodalNKTLNHID1689.html
LeukemiasFollicular dendritic cell in lymphomas of follicular originCarbone A, Gloghini Ahttp://atlasgeneticsoncology.org/Anomalies/FollDendriticCellID1783.html
LeukemiasHistiocytic SarcomaConde Royo D, Juárez-Salcedo LM, Dalia S.http://atlasgeneticsoncology.org/Anomalies/HistiocyticSarcID1724.html
LeukemiasIndeterminate Dendritic Cell TumorConde Royo D, Juárez-Salcedo LM, Dalia S.http://atlasgeneticsoncology.org/Anomalies/IndeterminDendritCellID1728.html
LeukemiasInterdigitating Dendritic Cell SarcomaConde Royo D, Juárez-Salcedo LM, Dalia S.http://atlasgeneticsoncology.org/Anomalies/InterdigitDendritCellSarcID1727.html
LeukemiasMyeloid sarcomaChisholm KMhttp://atlasgeneticsoncology.org/Anomalies/MyeloidSarcomaID1822.html
LeukemiasNodal marginal zone lymphoma (NMZL)Chen DBhttp://atlasgeneticsoncology.org/Anomalies/NMZLID2145.html
LeukemiasOcular adnexal marginal zone lymphoma (OAMZL)Bongiovanni L and Ponzoni Mhttp://atlasgeneticsoncology.org/Anomalies/OcularAdnexalMZLID1778.html
LeukemiasPlasmacytoma (Solitary bone plasmacytoma, extramedullary plasmacytoma)Rowell S, Ho M, Bianchi G, Anderson KChttp://atlasgeneticsoncology.org/Anomalies/PlasmacytomaID1759.html
LeukemiasTBL1XR1/MECOM fusionAbdo C, Passet M, Maarek O, Clappier Ehttp://atlasgeneticsoncology.org/Anomalies/del3q26TBL1XR1-MECOMID1823.html
Leukemiasder(17)t(17;17)(p13;q12-21)Zamecnikova Ahttp://atlasgeneticsoncology.org/Anomalies/t1717p13q12_21ID1820.html
Leukemiasder(2)t(1;2)(q12-21;q37)Zamecnikova Ahttp://atlasgeneticsoncology.org/Anomalies/t0102q12q37ID1821.html
Leukemiasder(20)t(1;20)(q12-21;p13) in hematological malignancesMitev L, Grachlyova L, Asenova Ahttp://atlasgeneticsoncology.org/Anomalies/t0120q12-21p13ID1789.html
Leukemiasder(3)t(3;3)(p25-26;q12-21)Zamecnikova Ahttp://atlasgeneticsoncology.org/Anomalies/t0303p25q12ID1824.html
Leukemiasder(4)t(1;4)(q11-32;q34-35)Zamecnikova Ahttp://atlasgeneticsoncology.org/Anomalies/t01q04q3ID1815.html
Leukemiasder(8;17)(q10;q10)Huret JLhttp://atlasgeneticsoncology.org/Anomalies/der0817q10q10ID1801.html
Leukemiasder(Y)t(Y;1)(q11-12;q12-21)Zamecnikova Ahttp://atlasgeneticsoncology.org/Anomalies/t0Yq01qID1818.html
Leukemiasdic(7;12)(p10-p12;p11-p13)Zamecnikova Ahttp://atlasgeneticsoncology.org/Anomalies/dic07p12pID1816.html
Leukemiasi(22)(q10) in myeloid malignanciesZamecnikova Ahttp://atlasgeneticsoncology.org/Anomalies/iso22qMyeloID1819.html
Leukemiasi(3)(q10) in non-Hodgkin's lymphoma (NHL)Zamecnikova Ahttp://atlasgeneticsoncology.org/Anomalies/i3q10ID2115.html
Leukemiasi(5)(p10) in hematological malignanciesZamecnikova Ahttp://atlasgeneticsoncology.org/Anomalies/i05p10ID1825.html
Leukemiasi(9)(p10)Zamecnikova Ahttp://atlasgeneticsoncology.org/Anomalies/i09p10ID1604.html
Leukemiasins(X;11)(q28;q23q23) KMT2A/FLNAGindina T, Zerkalenkova E, Olshanskaya Yhttp://atlasgeneticsoncology.org/Anomalies/ins0X11q28q23q23KMT2A_FLNAID1804.html
Leukemiast(10;10)(p12;q21) CTNNA3/ARHGAP21Huret JLhttp://atlasgeneticsoncology.org/Anomalies/t1010p12q21ID1835.html
Leukemiast(11;12)(p15;q13) NUP98/HOXC11Huret JLhttp://atlasgeneticsoncology.org/Anomalies/t1112ID1185.html
Leukemiast(11;14)(p13;q32) IGH/CD44Huret JLhttp://atlasgeneticsoncology.org/Anomalies/t1114p13q32ID1609.html
Leukemiast(11;16)(q23;q24) KMT2A/USP10Zerkalenkova E, Lebedeva S, Kazakova A, Baryshev P, Meyer C, Marschalek R, Novichkova G, Maschan M, Maschan A, Olshanskaya Yhttp://atlasgeneticsoncology.org/Anomalies/t1116q23q24KMT2A-USP10ID1802.html
Leukemiast(11;17)(q23;q21) KMT2A/ACACAHuret JLhttp://atlasgeneticsoncology.org/Anomalies/t1117q23q21ID1414.html
Leukemiast(11;19)(q23;p13) KMT2A/MYO1FHuret JLhttp://atlasgeneticsoncology.org/Anomalies/t1119q23p13ID1406.html
Leukemiast(14;16)(q32;q23) IGH/MAFMitev L, Grahlyova L, Asenova Ahttp://atlasgeneticsoncology.org/Anomalies/t1416q32q23IGH-MAFID1308.html
Leukemiast(14;20)(q32;q12) IGH/MAFB in Plasma Cell MyelomaMicale MAhttp://atlasgeneticsoncology.org/Anomalies/t1420q32q12IGHMAFBID1313.html
Leukemiast(1;1)(q24;q25) RCSD1/ABL2Gaillard Bhttp://atlasgeneticsoncology.org/Anomalies/inv1q24q25RCSD1ABL2ID1831.html
Leukemiast(1;11)(q24;p15) NUP98/PRRX1Zamecnikova Ahttp://atlasgeneticsoncology.org/Anomalies/t0111q23p15ID1169.html
Leukemiast(1;5)(q21;q32) PDE4DIP/PDGFRBZamecnikova Ahttp://atlasgeneticsoncology.org/Anomalies/t0105q22q33ID1115.html
Leukemiast(20;21)(q11;q22) RUNX1/NOL4LHuret JLhttp://atlasgeneticsoncology.org/Anomalies/t2021q11q22ID1307.html
Leukemiast(2;9)(p24;p13) PAX5/KIDINS220Gindina Thttp://atlasgeneticsoncology.org/Anomalies/t0209p24p13PAX5_KIDINS220ID1805.html
Leukemiast(3;5)(q26;q31) H2AFY/MECOMHuret JLhttp://atlasgeneticsoncology.org/Anomalies/t0305q26q31H2AFY_MECOMID1837.html
Leukemiast(3;8)(p25;q24)Huret JLhttp://atlasgeneticsoncology.org/Anomalies/t0308p25q24ID1827.html
Leukemiast(4;12)(q21;p13)Gindina Thttp://atlasgeneticsoncology.org/Anomalies/t0412q21p13ID1504.html
Leukemiast(5;9)(q35;q34) SQSTM1/NUP214Huret JLhttp://atlasgeneticsoncology.org/Anomalies/t0509q35q34ID1833.html
Leukemiast(6;17)(p21;p13)Zamecnikova Ahttp://atlasgeneticsoncology.org/Anomalies/t0617p21p13ID1814.html
Leukemiast(6;8)(p21;q24) MYC/SUPT3HAl Moosawi M, Bruyère Hhttp://atlasgeneticsoncology.org/Anomalies/t0608p21q24SUPT3H-MYCID2987.html
Leukemiast(7;14)(q35;q32.1) TRB/TCL1AGindina Thttp://atlasgeneticsoncology.org/Anomalies/inv14ID2049.html
Leukemiast(8;14)(q24;q32) in BPDCNHuret JLhttp://atlasgeneticsoncology.org/Anomalies/t0814q24q32BPDCNID1828.html
Leukemiast(9;22)(p24;q11.2) BCR/JAK2Gindina Thttp://atlasgeneticsoncology.org/Anomalies/t0922p24q11ID1331.html
Leukemiast(X;8)(q24;q24)Huret JLhttp://atlasgeneticsoncology.org/Anomalies/t0X08q24q24ID1826.html
Solid TumorsBone: Conventional OsteosarcomaFranceschini N, Cleton-Jansen AM, Bovée JVMGhttp://atlasgeneticsoncology.org/Anomalies/t0X08q24q24ID1826.html
Solid TumorsBone: EnchondromaWilpshaar TAH, Bovée JVMGhttp://atlasgeneticsoncology.org/Anomalies/t0X08q24q24ID1826.html
Solid TumorsBone: OsteochondromaWilpshaar TAH, Bovée JVMGhttp://atlasgeneticsoncology.org/Anomalies/t0X08q24q24ID1826.html
Cancer-PronesFamilial gliomaBazzoni R., Bentivegna Ahttp://atlasgeneticsoncology.org/Kprones/FamilialGliomaID10123.html
Deep InsightsDoes DNA ploidy and synthesis phase dynamic accentuate the predictive power of oestrogen and progesterone receptors in breast cancer progression and prognosis?Sherbet GV, Dlay SShttp://atlasgeneticsoncology.org/Deep/DNAploidyERandPRinBreastCancerID20148.html


X Y 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 NA


Home   Genes   Leukemias   Solid Tumors   Cancer-Prone   Deep Insight   Case Reports   Journals  Portal   Teaching   

© Atlas of Genetics and Cytogenetics in Oncology and Haematology
indexed on : Mon Oct 14 17:52:09 CEST 2019